Zyla Life Sciences Deferred Revenue
Zyla Life Sciences had Deferred Revenue of $7.46 million as of 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-03-16
- 2017-12-31: Deferred Revenue, Current $7.46M.
- 2017-09-30: Deferred Revenue, Current $8.76M.
- 2017-06-30: Deferred Revenue, Current $6.19M.
- 2017-03-31: Deferred Revenue, Current $6.17M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2017-12-31 | $7.46M 10-K · filed 2018-03-16 |
| 2017-09-30 | $8.76M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $6.19M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $6.17M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.98M 10-K · filed 2018-03-16 |
| 2016-09-30 | $4.91M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $7.18M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $8.37M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $10.13M 10-K · filed 2017-03-13 |
| 2015-09-30 | $13.72M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $15.11M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $15.95M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $588.00K 10-K · filed 2016-03-11 |
| 2014-09-30 | $551.00K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $551.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $551.00K 10-Q · filed 2014-06-11 |
| 2013-12-31 | $557.00K 10-K · filed 2015-03-16 |